Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician?

被引:29
|
作者
Song, Lixin [1 ,2 ]
Chen, Ronald C. [2 ,3 ,4 ]
Bensen, Jeannette T. [2 ,5 ]
Knafl, George J. [1 ]
Nielsen, Matthew E. [6 ]
Farnan, Laura [2 ]
Wallen, Eric M. [6 ]
Mishel, Merle [1 ,2 ]
Pruthi, Raj S. [6 ]
Mohler, James L. [2 ,7 ]
Godley, Paul A. [2 ,4 ,5 ,8 ]
机构
[1] Univ N Carolina, Sch Nursing, Adult & Geriatr Hlth Div, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Radiat Oncol, Sch Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Div Urol Surg, Sch Med, Chapel Hill, NC 27599 USA
[7] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[8] Univ N Carolina, Div Hematol Oncol, Sch Med, Chapel Hill, NC 27599 USA
关键词
decision-making; localized prostate cancer; subjective-affective factors; cancer aggressiveness; age; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; CARE NEEDS; MEN; PARTICIPATION; INFORMATION; REGRET; INTERVENTION; PREFERENCES; INVOLVEMENT;
D O I
10.1002/cncr.27738
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N = 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory variables and the nominal 3-level decision-making variable: patient-only, patient-physician shared, and physician-only. RESULTS: Approximately 41% of patients reported patient-only decision-making, 45% reported shared decision-making, and 13% reported physician-only decision-making. The odds of patient-only over physician-only decision-making were greater for younger men (vs those aged = 65 years) (odds ratio [OR], 1.68; 95% confidence interval [95% CI], 1.03-2.74), and were less for men with high (vs low) cancer aggressiveness (OR,0.29; 95% CI, 0.15-0.55). The odds of shared over physician-only decision-making were less for men with high (vs low) cancer aggressiveness (OR, 0.40; 95% CI, 0.22-0.73). Greater odds of patient-only and shared decision-making also were found to be associated with greater concerns about the physical impact of treatment and having enough time for decision-making and lower scores of receiving advice from others. CONCLUSIONS: The findings of the current study indicate that, to facilitate a more patient-oriented decision-making process regarding treatment in those with clinically localized prostate cancer, clinicians need to tailor their interventions according to patient age and cancer aggressiveness, help reduce patient concerns and misconceptions regarding the physical impact of treatments, allow sufficient time for patients to consider treatment options, and assist patients in balancing advice and information received from different sources. Cancer 2013. (c) 2012 American Cancer Society.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 50 条
  • [31] Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer
    D'Amico, Anthony V.
    Hui-Chen, Ming
    Renshaw, Andrew A.
    Sussman, Brenda
    Roehl, Kimberly A.
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (06): : S11 - S15
  • [32] The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer
    Timothy A. Masterson
    Karim Touijer
    [J]. Magnetic Resonance Materials in Physics, Biology and Medicine, 2008, 21 : 371 - 377
  • [33] The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer
    Masterson, Timothy A.
    Touijer, Karim
    [J]. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2008, 21 (06) : 371 - 377
  • [34] The effect of prostate biopsy timing on staging by prostate MRI in the treatment of clinically localized prostate cancer
    Cho, Soung Yong
    Cho, Kang Su
    Choi, Young Deuk
    Hong, Sung Joon
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 247 - 247
  • [35] Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer
    Sommers, Benjamin D.
    Beard, Clair J.
    D'Amico, Anthony V.
    Dahl, Douglas
    Kaplan, Irving
    Richie, Jerome P.
    Zeckhauser, Richard J.
    [J]. CANCER, 2007, 110 (10) : 2210 - 2217
  • [36] Racial differences in initial treatment for clinically localized prostate cancer.
    Hoffman, RM
    Harlan, LC
    Klabunde, C
    Hunt, WC
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 161 - 161
  • [37] Watchful waiting as a treatment option in the management of clinically localized prostate cancer
    Chodak, GW
    [J]. RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 235 - 239
  • [38] Recommendations by Canadian radiation oncologists for the treatment of clinically localized prostate cancer
    Pearce, A.
    Husain, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S30 - S30
  • [39] Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the prostate cancer outcomes study.
    Hoffman, RM
    Hunt, WC
    Gilliland, FD
    Stephenson, RA
    Potosky, AL
    [J]. CANCER, 2003, 97 (07) : 1653 - 1662
  • [40] Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer
    Austria, Mia
    Kimberlin, Colin
    Le, Tiffany
    Lynch, Kathleen A.
    Ehdaie, Behfar
    Atkinson, Thomas M.
    Vickers, Andrew J.
    Carlsson, Sigrid V.
    [J]. MDM POLICY & PRACTICE, 2023, 8 (01)